Compare Davita Inc (DVA) vs Eaton Corporation plc (ETN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs Eaton Corporation plc — how do they compare? Davita Inc trades at $179.25 (market cap $11.29B), while Eaton Corporation plc trades at $429.65 (market cap $164.88B). The key difference: Eaton Corporation plc is far larger — about 14.6× Davita Inc's market cap, and Eaton Corporation plc pays a 1.04% dividend while Davita Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 114 Days and Eaton Corporation plc for 31 Days on average.
| DVA | ETN | |
|---|---|---|
Market Cap | $11.29B | $164.88B |
Volume | 582,204 | 2,535,086 |
Sector | Health | Industrials |
52-Week High | $240.96 | $459.96 |
52-Week Low | $103.87 | $315.82 |
Typical Hold Time | 114 Days | 31 Days |
Enterprise Value | $24.01B | $185.51B |
Dividend Yield | — | 1.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $177.02, up 0.14% with a bearish technical signal despite recent earnings beats. The stock shows strong profitability with 32.36% gross margins and 635.3% ROE, though net income margin declined to 5.47% in 2025. Recent partnership expansions with Humana for value-based kidney care and institutional buying by BlackRock provide positive catalysts. Valuation appears reasonable with P/E of 15 and P/S of 0.88, below sector averages.
Outlook remains mixed with analyst consensus target of $235.67 suggesting 33% upside, but technical indicators signal near-term caution. Key risks include regulatory pressures on healthcare reimbursements and rising debt-to-asset ratio reaching 65.55%. Earnings momentum from three consecutive quarterly beats supports fundamental strength, though margin compression warrants monitoring.
Eaton Corporation (ETN) trades at $424.51, down 1.58% on the day, amid a near-term bearish technical signal. The company demonstrates strong fundamental health with consistent earnings beats in recent quarters, a 12.75% net income margin, and robust revenue growth, reaching $30.0B in 2026. Recent strategic acquisitions, such as the COL Group announced on September 25, 2026, aim to expand its footprint in high-growth data center and utility markets.
The outlook is supported by a unanimous bullish analyst consensus with a $502.38 price target, though risks include a high P/E ratio of 43.23 and significant capital expenditure reflected in the 2026 investing cash flow of -$12.3B. The stock's near-term performance hinges on the upcoming Q3 2026 earnings result against a $3.53 EPS expectation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About Eaton Corporation plc
Eaton is a global power management company providing energy-efficient solutions for electrical, aerospace, and industrial sectors. It focuses on improving sustainability through intelligent power technology.
Read more on ETN →
